Condition

Ocular Infections, Irritations and Inflammations (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Kala Pharmaceuticals, Inc. (1)

Collaborator

Intervention

kpi-121 0.25% (1)

kpi-121 1.0% (1)

vehicle of kpi-121 0.25% (1)

vehicle of kpi-121 1.0% (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

ocular infections, irritations and inflammations

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Ocular Infections, Irritations and Inflammations Trial in United States (KPI-121 0.25%, KPI-121 1.0%, Vehicle of KPI-121 0.25%)

Completed

Ocular Infections, Irritations and Inflammations

KPI-121 0.25%
+3 more

Artesia, California
+22 more

Jan 6, 2021